je.st
news
Gilead profits continue to rise on strength of HIV drugs
2013-02-05 05:42:42| Biotech - Topix.net
Gilead Sciences on Monday reported higher-than-expected quarterly profit and revenue as sales of the Foster City company's flagship HIV drugs exceeded Wall Street estimates.
Tags: continue
rise
strength
drugs
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||